Skip to Main Content

Paper Details

Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.
Am J Transplant
13
2021
IL-17, ITx, TNF, TNF-, Th17, Th17) cells, advanced intestinal failure, allograft, blood, effector memory T cells, immunosuppression, infliximab, intra-, intra-graft memory TNF- and IL-17 double-positive T helper type 17, memory T, patients, posttransplant malignancies
Author NameAffiliation
Alexander KroemerThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
Khalid Mohammed KhanThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
Bhaskar KallakuryMedStar Georgetown University Hospital
Nada YazigiThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
Stuart S KaufmanThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
Michael ZasloffThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
Thomas M FishbeinThe Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center
  • 1 - 7

Datasets

Release 1.2